XML 89 R53.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries [Abstract] |
Supplemental Condensed Consolidating Balance Sheet | SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of December 31, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 97 |  |  | $ | 2 |  |  | $ | 1 |  |  | $ | 213 |  |  | $ | — |  |  | $ | 313 |
Restricted cash | — |  |  | 1 |  |  | 40 |  |  | 10 |  |  | — |  |  | 51 |
Accounts receivable, net | — |  |  | 91 |  |  | 221 |  |  | 337 |  |  | — |  |  | 649 |
Notes receivable, net | — |  |  | — |  |  | 94 |  |  | 12 |  |  | — |  |  | 106 |
Inventories | — |  |  | 53 |  |  | 113 |  |  | 87 |  |  | (9 | ) |  | 244 |
Prepaid expenses, deposits and other current assets | 9 |  |  | 62 |  |  | 84 |  |  | 97 |  |  | — |  |  | 252 |
Property and equipment, net | 31 |  |  | 95 |  |  | 197 |  |  | 209 |  |  | (32 | ) |  | 500 |
Operating lease right-of-use, net | 1 |  |  | 24 |  |  | 30 |  |  | 50 |  |  | — |  |  | 105 |
Investment in subsidiaries | 3,133 |  |  | 1,024 |  |  | 1,153 |  |  | — |  |  | (5,310 | ) |  | — |
Goodwill | — |  |  | 240 |  |  | 1,897 |  |  | 1,143 |  |  | — |  |  | 3,280 |
Intangible assets, net | 31 |  |  | 34 |  |  | 1,087 |  |  | 364 |  |  | — |  |  | 1,516 |
Intercompany balances | — |  |  | 5,845 |  |  | — |  |  | — |  |  | (5,845 | ) |  | — |
Software, net | 46 |  |  | 36 |  |  | 94 |  |  | 82 |  |  | — |  |  | 258 |
Other assets(2) | 87 |  |  | 411 |  |  | 49 |  |  | 313 |  |  | (325 | ) |  | 535 |
Total assets | $ | 3,435 |  |  | $ | 7,918 |  |  | $ | 5,060 |  |  | $ | 2,917 |  |  | $ | (11,521 | ) |  | $ | 7,809 |
Liabilities and stockholders’ (deficit) equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | — |  |  | $ | 42 |  |  | $ | 2 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 45 |
Other current liabilities | 52 |  |  | 190 |  |  | 256 |  |  | 248 |  |  | (25 | ) |  | 721 |
Long-term debt, excluding current portion | — |  |  | 8,673 |  |  | 7 |  |  | — |  |  | — |  |  | 8,680 |
Operating lease liabilities | 1 |  |  | 19 |  |  | 25 |  |  | 43 |  |  | — |  |  | 88 |
Other long-term liabilities | 52 |  |  | 22 |  |  | 547 |  |  | 179 |  |  | (417 | ) |  | 383 |
Intercompany balances | 5,542 |  |  | — |  |  | 3 |  |  | 300 |  |  | (5,845 | ) |  | — |
Total SGC stockholders’ (deficit) equity | (2,212 | ) |  | (1,028 | ) |  | 4,220 |  |  | 2,042 |  |  | (5,234 | ) |  | (2,212 | )
Noncontrolling interest | — |  |  | — |  |  | — |  |  | 104 |  |  | — |  |  | 104 |
Total liabilities and stockholders’ (deficit) equity | $ | 3,435 |  |  | $ | 7,918 |  |  | $ | 5,060 |  |  | $ | 2,917 |  |  | $ | (11,521 | ) |  | $ | 7,809 |
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, the 2026 Unsecured Notes, which were issued in March 2019, and the 2028 Unsecured Notes and the 2029 Unsecured Notes, which were issued in November 2019.
(2) Includes $11 million in non-current restricted cash for Guarantor Subsidiaries.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of December 31, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 74 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 94 |  |  | $ | (1 | ) |  | $ | 168 |
Restricted cash | — |  |  | 1 |  |  | 32 |  |  | 6 |  |  | — |  |  | 39 |
Accounts receivable, net | — |  |  | 79 |  |  | 205 |  |  | 315 |  |  | — |  |  | 599 |
Notes receivable, net | — |  |  | — |  |  | 101 |  |  | 13 |  |  | — |  |  | 114 |
Inventories | — |  |  | 40 |  |  | 82 |  |  | 111 |  |  | (17 | ) |  | 216 |
Prepaid expenses, deposits and other current assets | 6 |  |  | 63 |  |  | 92 |  |  | 72 |  |  | — |  |  | 233 |
Property and equipment, net | 31 |  |  | 112 |  |  | 219 |  |  | 218 |  |  | (33 | ) |  | 547 |
Investment in subsidiaries | 2,836 |  |  | 975 |  |  | 1,093 |  |  | — |  |  | (4,904 | ) |  | — |
Goodwill | — |  |  | 240 |  |  | 1,897 |  |  | 1,143 |  |  | — |  |  | 3,280 |
Intangible assets, net | 43 |  |  | 34 |  |  | 1,291 |  |  | 441 |  |  | — |  |  | 1,809 |
Intercompany balances | — |  |  | 6,054 |  |  | — |  |  | — |  |  | (6,054 | ) |  | — |
Software, net | 58 |  |  | 39 |  |  | 128 |  |  | 60 |  |  | — |  |  | 285 |
Other assets(2) | 110 |  |  | 404 |  |  | 46 |  |  | 308 |  |  | (440 | ) |  | 428 |
Total assets | $ | 3,158 |  |  | $ | 8,042 |  |  | $ | 5,186 |  |  | $ | 2,781 |  |  | $ | (11,449 | ) |  | $ | 7,718 |
Liabilities and stockholders’ (deficit) equity |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | — |  |  | $ | 42 |  |  | $ | — |  |  | $ | 3 |  |  | $ | — |  |  | $ | 45 |
Other current liabilities | 64 |  |  | 162 |  |  | 248 |  |  | 254 |  |  | (26 | ) |  | 702 |
Long-term debt, excluding current portion | — |  |  | 8,991 |  |  | — |  |  | 1 |  |  | — |  |  | 8,992 |
Other long-term liabilities | 106 |  |  | 8 |  |  | 637 |  |  | 172 |  |  | (481 | ) |  | 442 |
Intercompany balances | 5,451 |  |  | — |  |  | 49 |  |  | 554 |  |  | (6,054 | ) |  | — |
Stockholders’ (deficit) equity | (2,463 | ) |  | (1,161 | ) |  | 4,252 |  |  | 1,797 |  |  | (4,888 | ) |  | (2,463 | )
Total liabilities and stockholders’ (deficit) equity | $ | 3,158 |  |  | $ | 8,042 |  |  | $ | 5,186 |  |  | $ | 2,781 |  |  | $ | (11,449 | ) |  | $ | 7,718 |
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, which were issued in October 2017 and February 2018, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
(2) Includes $12 million and $1 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
Supplemental Condensed Consolidating Statement of Operations and Comprehensive Loss | SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Year Ended December 31, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 590 |  |  | $ | 1,538 |  |  | $ | 1,648 |  |  | $ | (376 | ) |  | $ | 3,400 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 387 |  |  | 446 |  |  | 776 |  |  | (325 | ) |  | 1,284 |
Selling, general and administrative | 132 |  |  | 35 |  |  | 223 |  |  | 360 |  |  | (43 | ) |  | 707 |
Research and development | — |  |  | 5 |  |  | 86 |  |  | 97 |  |  | — |  |  | 188 |
Depreciation, amortization and impairments | 53 |  |  | 40 |  |  | 392 |  |  | 180 |  |  | (18 | ) |  | 647 |
Restructuring and other | 4 |  |  | 1 |  |  | 6 |  |  | 17 |  |  | — |  |  | 28 |
Operating (loss) income | (189 | ) |  | 122 |  |  | 385 |  |  | 218 |  |  | 10 |  |  | 546 |
Interest expense | — |  |  | (588 | ) |  | — |  |  | (1 | ) |  | — |  |  | (589 | )
Loss on debt financing transactions | — |  |  | (100 | ) |  | — |  |  | — |  |  | — |  |  | (100 | )
Gain on remeasurement of debt | — |  |  | 9 |  |  | — |  |  | — |  |  | — |  |  | 9 |
Other income (expense), net | 191 |  |  | 586 |  |  | (660 | ) |  | (91 | ) |  | — |  |  | 26 |
Net income (loss) before equity in (loss) income of subsidiaries and income taxes | 2 |  |  | 29 |  |  | (275 | ) |  | 126 |  |  | 10 |  |  | (108 | )
Equity in (loss) income of subsidiaries | (109 | ) |  | 8 |  |  | 6 |  |  | — |  |  | 95 |  |  | — |
Income tax (expense) benefit | (23 | ) |  | (8 | ) |  | 65 |  |  | (44 | ) |  | — |  |  | (10 | )
Net (loss) income | (130 | ) |  | 29 |  |  | (204 | ) |  | 82 |  |  | 105 |  |  | (118 | )
Less: Net income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 12 |  |  | — |  |  | 12 |
Net (loss) income attributable to SGC | $ | (130 | ) |  | $ | 29 |  |  | $ | (204 | ) |  | $ | 70 |  |  | $ | 105 |  |  | $ | (130 | )
Net (loss) income | $ | (130 | ) |  | $ | 29 |  |  | $ | (204 | ) |  | $ | 82 |  |  | $ | 105 |  |  | $ | (118 | )
Other comprehensive income (loss) | 8 |  |  | 9 |  |  | (2 | ) |  | (1 | ) |  | (6 | ) |  | 8 |
Total comprehensive (loss) income | (122 | ) |  | 38 |  |  | (206 | ) |  | 81 |  |  | 99 |  |  | (110 | )
Less: comprehensive income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 12 |  |  | — |  |  | 12 |
Comprehensive (loss) income attributable to SGC | $ | (122 | ) |  | $ | 38 |  |  | $ | (206 | ) |  | $ | 69 |  |  | $ | 99 |  |  | $ | (122 | )
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, the 2026 Unsecured Notes, which were issued in March 2019, and the 2028 Unsecured Notes and the 2029 Unsecured Notes, which were issued in November 2019.
(2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Year Ended December 31, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 547 |  |  | $ | 1,654 |  |  | $ | 1,540 |  |  | $ | (378 | ) |  | $ | 3,363 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 361 |  |  | 490 |  |  | 721 |  |  | (317 | ) |  | 1,255 |
Selling, general and administrative | 154 |  |  | 42 |  |  | 227 |  |  | 326 |  |  | (52 | ) |  | 697 |
Research and development | — |  |  | 3 |  |  | 87 |  |  | 112 |  |  | — |  |  | 202 |
Depreciation, amortization and impairments | 44 |  |  | 33 |  |  | 440 |  |  | 188 |  |  | (15 | ) |  | 690 |
Restructuring and other | 195 |  |  | (1 | ) |  | 9 |  |  | 50 |  |  | — |  |  | 253 |
Operating (loss) income | (393 | ) |  | 109 |  |  | 401 |  |  | 143 |  |  | 6 |  |  | 266 |
Interest expense | — |  |  | (596 | ) |  | — |  |  | (1 | ) |  | — |  |  | (597 | )
Loss on debt financing transactions | — |  |  | (93 | ) |  | — |  |  | — |  |  | — |  |  | (93 | )
Gain on remeasurement of debt | — |  |  | 43 |  |  | — |  |  | — |  |  | — |  |  | 43 |
Other income (expense), net | 336 |  |  | 535 |  |  | (745 | ) |  | (84 | ) |  | — |  |  | 42 |
Net (loss) income before equity in (loss) income of subsidiaries and income taxes | (57 | ) |  | (2 | ) |  | (344 | ) |  | 58 |  |  | 6 |  |  | (339 | )
Equity in (loss) income of subsidiaries | (219 | ) |  | 44 |  |  | (28 | ) |  | — |  |  | 203 |  |  | — |
Income tax (expense) benefit | (76 | ) |  | — |  |  | 82 |  |  | (19 | ) |  | — |  |  | (13 | )
Net (loss) income | $ | (352 | ) |  | $ | 42 |  |  | $ | (290 | ) |  | $ | 39 |  |  | $ | 209 |  |  | $ | (352 | )
Other comprehensive (loss) income | (100 | ) |  | 30 |  |  | (66 | ) |  | (114 | ) |  | 150 |  |  | (100 | )
Comprehensive (loss) income | $ | (452 | ) |  | $ | 72 |  |  | $ | (356 | ) |  | $ | (75 | ) |  | $ | 359 |  |  | $ | (452 | )
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, which were issued in October 2017 and February 2018, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
(2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Year Ended December 31, 2017
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 498 |  |  | $ | 1,684 |  |  | $ | 1,223 |  |  | $ | (321 | ) |  | $ | 3,084 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 342 |  |  | 511 |  |  | 629 |  |  | (318 | ) |  | 1,164 |
Selling, general and administrative | 127 |  |  | 41 |  |  | 244 |  |  | 250 |  |  | (49 | ) |  | 613 |
Research and development | 2 |  |  | 7 |  |  | 101 |  |  | 74 |  |  | — |  |  | 184 |
Depreciation, amortization and impairments | 72 |  |  | 31 |  |  | 463 |  |  | 128 |  |  | (11 | ) |  | 683 |
Restructuring and other | 30 |  |  | 5 |  |  | 7 |  |  | 4 |  |  | — |  |  | 46 |
Operating (loss) income | (231 | ) |  | 72 |  |  | 358 |  |  | 138 |  |  | 57 |  |  | 394 |
Interest expense | (5 | ) |  | (604 | ) |  | — |  |  | (1 | ) |  | — |  |  | (610 | )
Loss on debt financing transactions | (1 | ) |  | (37 | ) |  | — |  |  | — |  |  | — |  |  | (38 | )
Other income (expense), net | 88 |  |  | 150 |  |  | (185 | ) |  | (26 | ) |  | — |  |  | 27 |
Net (loss) income before equity in income of subsidiaries and income taxes | (149 | ) |  | (419 | ) |  | 173 |  |  | 111 |  |  | 57 |  |  | (227 | )
Equity in (loss) income of subsidiaries | (45 | ) |  | 67 |  |  | 22 |  |  | — |  |  | (44 | ) |  | — |
Income tax (expense) benefit | (48 | ) |  | 158 |  |  | (86 | ) |  | (39 | ) |  | — |  |  | (15 | )
Net (loss) income | $ | (242 | ) |  | $ | (194 | ) |  | $ | 109 |  |  | $ | 72 |  |  | $ | 13 |  |  | $ | (242 | )
Other comprehensive income | 134 |  |  | 10 |  |  | 66 |  |  | 129 |  |  | (205 | ) |  | 134 |
Comprehensive (loss) income | $ | (108 | ) |  | $ | (184 | ) |  | $ | 175 |  |  | $ | 201 |  |  | $ | (192 | ) |  | $ | (108 | )
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the 2022 Unsecured Notes, which were redeemed in April and December 2019, and the 2025 Secured Notes, which were issued in October 2017 and February 2018.
(2) Exclusive of D&A.
Supplemental Condensed Consolidating Statement of Cash Flows | SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Year Ended December 31, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non- Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities | $ | (57 | ) |  | $ | 173 |  |  | $ | 109 |  |  | $ | 320 |  |  | $ | 1 |  |  | $ | 546 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (22 | ) |  | (28 | ) |  | (112 | ) |  | (123 | ) |  | — |  |  | (285 | )
Distributions of capital from equity investments | — |  |  | — |  |  | — |  |  | 23 |  |  | — |  |  | 23 |
Additions to equity method investments | — |  |  | (1 | ) |  | — |  |  | — |  |  | — |  |  | (1 | )
Other, principally change in intercompany investing activities | — |  |  | 289 |  |  | — |  |  | — |  |  | (289 | ) |  | — |
Net cash (used in) provided by investing activities | (22 | ) |  | 260 |  |  | (112 | ) |  | (100 | ) |  | (289 | ) |  | (263 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Payments on long-term debt, net of proceeds | — |  |  | (395 | ) |  | — |  |  | (2 | ) |  | — |  |  | (397 | )
Payments of debt issuance and deferred financing costs | — |  |  | (34 | ) |  | — |  |  | (1 | ) |  | — |  |  | (35 | )
Payments on license obligations | (27 | ) |  | (1 | ) |  | (10 | ) |  | (2 | ) |  | — |  |  | (40 | )
Sale of future revenue | — |  |  | — |  |  | 11 |  |  | — |  |  | — |  |  | 11 |
Net proceeds from the sale of SciPlay common stock | — |  |  | — |  |  | — |  |  | 342 |  |  | — |  |  | 342 |
Payments of deferred SciPlay common stock offering costs | — |  |  | — |  |  | — |  |  | (9 | ) |  | — |  |  | (9 | )
Net redemptions of common stock under stock-based compensation plans and other | 7 |  |  | (2 | ) |  | (4 | ) |  | (2 | ) |  | — |  |  | (1 | )
Other, principally change in intercompany financing activities | 122 |  |  | — |  |  | 15 |  |  | (426 | ) |  | 289 |  |  | — |
Net cash provided by (used in) financing activities | 102 |  |  | (432 | ) |  | 12 |  |  | (100 | ) |  | 289 |  |  | (129 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | 1 |
Increase in cash, cash equivalents and restricted cash | 23 |  |  | 1 |  |  | 9 |  |  | 121 |  |  | 1 |  |  | 155 |
Cash, cash equivalents, and restricted cash, beginning of period | 74 |  |  | 2 |  |  | 43 |  |  | 102 |  |  | (1 | ) |  | 220 |
Cash, cash equivalents and restricted cash, end of period | $ | 97 |  |  | $ | 3 |  |  | $ | 52 |  |  | $ | 223 |  |  | $ | — |  |  | $ | 375 |
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, the 2026 Unsecured Notes, which were issued in March 2019, and the 2028 Unsecured Notes and the 2029 Unsecured Notes, which were issued in November 2019.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Year Ended December 31, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non- Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities | $ | (221 | ) |  | $ | 18 |  |  | $ | 206 |  |  | $ | 341 |  |  | $ | 2 |  |  | $ | 346 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (35 | ) |  | (63 | ) |  | (146 | ) |  | (147 | ) |  | — |  |  | (391 | )
Acquisitions of businesses and assets, net of cash acquired | — |  |  | — |  |  | (32 | ) |  | (265 | ) |  | — |  |  | (297 | )
Proceeds from asset sales | — |  |  | — |  |  | 40 |  |  | — |  |  | — |  |  | 40 |
Acquisitions and additions to equity method investments | — |  |  | (2 | ) |  | — |  |  | (178 | ) |  | — |  |  | (180 | )
Distributions of capital from equity investments | — |  |  | — |  |  | — |  |  | 30 |  |  | — |  |  | 30 |
Other, principally change in intercompany investing activities | — |  |  | (159 | ) |  | — |  |  | — |  |  | 159 |  |  | — |
Net cash used in investing activities | (35 | ) |  | (224 | ) |  | (138 | ) |  | (560 | ) |  | 159 |  |  | (798 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Payments on long-term debt, net of proceeds | — |  |  | 246 |  |  | — |  |  | (8 | ) |  | — |  |  | 238 |
Payments of assumed NYX debt and other acquisitions debt | — |  |  | — |  |  | (2 | ) |  | (288 | ) |  | — |  |  | (290 | )
Payments of debt issuance and deferred financing costs | — |  |  | (38 | ) |  | — |  |  | — |  |  | — |  |  | (38 | )
Payments on license obligations | (43 | ) |  | — |  |  | (2 | ) |  | — |  |  | — |  |  | (45 | )
Net redemptions of common stock under stock-based compensation plans and other | (18 | ) |  | — |  |  | (3 | ) |  | — |  |  | — |  |  | (21 | )
Other, principally change in intercompany financing activities | (342 | ) |  | — |  |  | (62 | ) |  | 563 |  |  | (159 | ) |  | — |
Net cash (used in) provided by financing activities | (403 | ) |  | 208 |  |  | (69 | ) |  | 267 |  |  | (159 | ) |  | (156 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | — |  |  | — |  |  | (6 | ) |  | — |  |  | (6 | )
(Decrease) increase in cash, cash equivalents and restricted cash | (659 | ) |  | 2 |  |  | (1 | ) |  | 42 |  |  | 2 |  |  | (614 | )
Cash, cash equivalents, and restricted cash, beginning of period | 733 |  |  | — |  |  | 44 |  |  | 60 |  |  | (3 | ) |  | 834 |
Cash, cash equivalents and restricted cash, end of period | $ | 74 |  |  | $ | 2 |  |  | $ | 43 |  |  | $ | 102 |  |  | $ | (1 | ) |  | $ | 220 |
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the 2022 Unsecured Notes, which were redeemed in April and December 2019, the 2025 Secured Notes, which were issued in October 2017 and February 2018, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Year Ended December 31, 2017
| SGC (Parent 1) |  | SGI (Issuer 2) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities | $ | (41 | ) |  | $ | (300 | ) |  | $ | 567 |  |  | $ | 283 |  |  | $ | (2 | ) |  | $ | 507 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (53 | ) |  | (31 | ) |  | (129 | ) |  | (81 | ) |  | — |  |  | (294 | )
Acquisitions of businesses, net of cash acquired | — |  |  | — |  |  | (26 | ) |  | (32 | ) |  | — |  |  | (58 | )
Acquisitions and additions to equity method investments | — |  |  | — |  |  | — |  |  | (107 | ) |  | — |  |  | (107 | )
Distributions of capital on equity investments | — |  |  | — |  |  | — |  |  | 34 |  |  | — |  |  | 34 |
Changes in other assets and liabilities and other | — |  |  | — |  |  | 8 |  |  | 2 |  |  | — |  |  | 10 |
Other, principally change in intercompany investing activities | — |  |  | (569 | ) |  | — |  |  | (120 | ) |  | 689 |  |  | — |
Net cash (used in) provided by investing activities | (53 | ) |  | (600 | ) |  | (147 | ) |  | (304 | ) |  | 689 |  |  | (415 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Net (payments) proceeds of long-term debt including senior notes and term loans | (250 | ) |  | 958 |  |  | — |  |  | (7 | ) |  | — |  |  | 701 |
Payments of debt issuance and deferred financing costs | — |  |  | (59 | ) |  | — |  |  | — |  |  | — |  |  | (59 | )
Payments on license obligations | (48 | ) |  | — |  |  | (5 | ) |  | — |  |  | — |  |  | (53 | )
Net redemptions of common stock under stock-based compensation plans and other | (8 | ) |  | — |  |  | (1 | ) |  | — |  |  | — |  |  | (9 | )
Other, principally change in intercompany financing activities | 1,100 |  |  | — |  |  | (411 | ) |  | — |  |  | (689 | ) |  | — |
Net cash provided by (used in) financing activities | 794 |  |  | 899 |  |  | (417 | ) |  | (7 | ) |  | (689 | ) |  | 580 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | — |  |  | — |  |  | 5 |  |  | — |  |  | 5 |
Increase (decrease) in cash, cash equivalents and restricted cash | 700 |  |  | (1 | ) |  | 3 |  |  | (23 | ) |  | (2 | ) |  | 677 |
Cash, cash equivalents, and restricted cash, beginning of period | 33 |  |  | 1 |  |  | 41 |  |  | 83 |  |  | (1 | ) |  | 157 |
Cash, cash equivalents and restricted cash, end of period | $ | 733 |  |  | $ | — |  |  | $ | 44 |  |  | $ | 60 |  |  | $ | (3 | ) |  | $ | 834 |
(1) Issuer of obligations under the 2020 Notes, which were redeemed in December 2019, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the 2022 Unsecured Notes, which were redeemed in April and December 2019, and the 2025 Secured Notes, which were issued in October 2017 and February 2018.

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | sgms_FinancialInformationForGuarantorSubsidiariesAndNonGuarantorSubsidiariesAbstract
Namespace Prefix: | sgms_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration